MASHURA LLC – Trademark Portfolio
Entity Type: 16
MASHURA LLC holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 8 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 7 trademarks are registered and 2 are pending. Notable registered marks include QBUD, BUDDY, CUBEX, ZIMBIS, and MYZIMBIS. The owner is based in PHOENIX, AZ.
3801 E. ROESER RD., #16
PHOENIX, AZ 85040
Showing of trademarks Trademarks
Trademark Classifications
MASHURA LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does MASHURA LLC have?
MASHURA LLC has 11 U.S. trademarks filed with the USPTO. Of these, 7 registered, 2 pending, 2 cancelled.
What trademark classes does MASHURA LLC file in?
MASHURA LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are MASHURA LLC's most well-known trademarks?
MASHURA LLC's registered trademark portfolio includes well-known marks such as QBUD, BUDDY, CUBEX, ZIMBIS, and MYZIMBIS. These are among 7 currently registered trademarks in the portfolio.
What is MASHURA LLC's trademark registration success rate?
MASHURA LLC has a 78% trademark registration rate, with 7 out of 9 resolved applications resulting in successful registration. Currently, 2 applications are pending review.